Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1442 of includes/bootstrap.inc).

GL E IX 2.4.3 Certificate of exhibition

As regards the requirements described in A‑IV, 3 ("Display at an exhibition"), for Euro-PCT applications the certificate of exhibition, where relevant, is to be filed within the 31-month time limit for entry into the European phase. If the document is not filed in due time, the applicant is informed of this in a communication under Rule 112(1).

GL E IX 2.4.2 Sequence listings

In relation to A‑IV, 5 ("Applications relating to nucleotide and amino acid sequences"), where the Euro-PCT application discloses nucleotide or amino acid sequences, a sequence listing in electronic form (i.e. in TXT format) drawn up in compliance with WIPO Standard ST.25 must be available to the EPO as designated/elected Office on expiry of the 31-month time limit.

GL E IX 2.4.1 Divisional applications

In relation to A‑IV, 1 ("European divisional applications") there is no provision in the PCT for filing divisional applications.

GL E IX 2.4 Instructions in Chapter A‑IV ("Special provisions")

2.4.1 Divisional applications

2.4.2 Sequence listings

2.4.3 Certificate of exhibition

2.4.4 Biological material

GL E IX 2.3.12 Renewal fees

The renewal fees for a Euro-PCT application are due in respect of the third and each subsequent year, calculated from the date of filing of the Euro-PCT application as accorded by the receiving Office.

GL E IX 2.3.11 Designation fee

The time limit for paying the designation fee is 31 months from the date of filing or, if priority has been claimed, from the earliest priority date (31-month time limit), if the time limit specified in Rule 39(1) has expired earlier (Rule 159(1)(d)) (see A‑III, 11.2.5, for further details).

GL E IX 2.3.10 Abstract

The abstract (see A‑III, 10 ("Abstract")) is included in the copy of the international application supplied to the EPO.

GL E IX 2.3.9 Drawings

The provisions of the EPC concerning the filing of drawings (see A‑II, 5, and A‑III, 3.2) are identical with the corresponding provisions of the PCT and therefore no supplementary examination is necessary, provided that the provisions of Rule 11 PCT have been complied with (see also E‑IX, 2.3.2).

GL E IX 2.3.8 Claims fee

The time limit for paying the claims fee referred to in A‑III, 9, is 31 months from the date of filing or, if priority has been claimed, from the earliest priority date (Rule 162(1)).

If they have not been paid by then, under Rule 162(2), they may still be paid within the six-month period under Rule 161(1) and (2).

GL E IX 2.3.7 Prohibited matter

As prohibited statements or matter may not necessarily be omitted under Art. 21(6) PCT, the application must be examined to ensure that the instructions in A‑III, 8 ("Prohibited matter") are complied with.